Abstract:
This disclosure provides improved method, kits, and systems and for isolating and enriching spermatogonial stem cells (SSCs) from livestock animal testicular tissue. In one aspect, the disclosure provides a method for enriching SSCs from a population of testis-derived cells containing at least one SSC, where the method comprises contacting the population of testis-derived cells to a culture media comprising, or that is preconditioned with, endothelial feeder cells, and maintaining culture conditions suitable for SSC cell maintenance and enrichment. In some embodiments, the media and culture conditions comprise one or more growth factors selected from GDNF, FGF2, SDF-1a, CSF-1, FDGF, NGF, and TGF-β, in any combination. In exemplary embodiments, the SSCs are porcine or bovine SSCs.
Abstract:
A composition includes a contraceptive chimeric virus-like particle with an antigenic carrier domain and one or more antigenic regions from a sperm cell in the antigenic carrier domain, with the antigenic carrier domain including human papillomavirus L1 capsid protein and the antigenic regions including one or more structural elements of the Catsper ion channel complex. When administered to a patient, the contraceptive vaccine stimulates production of anti-sperm antibodies that, upon binding to a sperm cell, inhibit the sperm cell's motility and thus inhibit the ability of the sperm cell to fertilize an egg cell. The induced immunoinfertility of the composition can be reversed for brief or extended lengths of time by overdosing the patient with a reversal agent lacking the antigenic carrier domain but having a protein sequence substantially identical to that of the one or more antigenic regions to sequester the anti-sperm antibodies.
Abstract:
The invention encompasses a method of estimating a distribution or a standard deviation of breeding values or predicted transmitting abilities of gametes from an individual using population-wide estimates of linkage disequilibrium for one or more genetic markers or genes, so as to more efficiently produce offspring having breeding values or predicted transmitting abilities that equal or exceed a desired breeding value or predicted transmitting ability.
Abstract:
A method for altering the properties of extracellular vesicles and exosomes for use in diagnosis and therapeutics is disclosed, through their production by primary cell culture under Applicant's specific controlled conditions. A mammalian ejaculate is provided and sperm therefrom are incubated, during which time aliquots are evaluated for production of vesicles engineered to contain the cargo of choice and targeted to the desired application through adjustment of the surface receptor complement. For example, vesicle-borne Fc receptors act as decoys to protect sperm from antibodies in the female tract and vesicles additionally deliver regulatory molecules to modulate tract function, enabling the ability to control release and to engineer sperm-derived vesicle/ exosome structures to be used in diagnosis of infertility and in production of sperm doses of superior performance.
Abstract:
A purified antibody, or an antigen-binding fragment thereof, is provided that binds selectively to a protein specific to an X-chromosome of a mammalian sperm cell. The sperm cell protein comprises an amino acid sequence set forth in SEQ ID NOs: 4 and 9-16. The antibody or antigen-binding fragment thereof may be derived by immunization of a host by an antigenic peptide composition comprising one or more natural or synthetic antigenic peptide sequences set forth as SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, and SEQ ID NOs: 4 and 9-16. The antibody finds utility in identifying an X-chromosome bearing sperm cell population, and in methods for skewing a sex ratio in mammals.
Abstract translation:提供纯化的抗体或其抗原结合片段,其选择性地结合哺乳动物精子细胞的X染色体特异的蛋白质。 精子细胞蛋白质包含SEQ ID NO:4和9-16所示的氨基酸序列。 抗体或其抗原结合片段可以通过由包含SEQ ID NO:1,SEQ ID NO:2,SEQ ID NO:1所示的一种或多种天然或合成抗原肽序列的抗原肽组合物免疫宿主而得到。 3和SEQ ID NO:4和9-16。 该抗体可用于鉴定携带X染色体的精子细胞群体,以及用于歪斜哺乳动物中性别比例的方法。
Abstract:
Methods for improving the functionality and/or fertility of sperm, for example, by enhancing motility and extending the lifespan of sperm in the FRT, by adding functional molecules of interest attached to a membrane anchoring agent-PEG conjugate to the surface of the sperm are provided. Such methods may be used in AI to reduce the number of sperm needed for insemination and to improve conception rates.
Abstract:
The present invention relates to the field of veterinary medicine, more specifically to compositions and methods useful for processing animal semen for use in assisted reproduction. The invention relates to a composition for separation of spermatozoa from a semen sample, comprising at least one salt of an alkali metal and/or an alkaline earth metal, EDTA, a zwitterion buffer, silane-coated silica particles and water, said composition having a pH of 7.0- 7.35 and an osmolarity of 300-345 mOsm. Furthermore it relates to a method for preparing spermatozoa from a semen sample from a non-human animal, comprising the step of separating the spermatozoa from other semen constituents by centrifugation through a single layer of a colloid formulation. Preferably, the colloid formulation is the composition according to the invention. The invention also relates to a method for separating a sperm sub-population of interest from a semen sample from a non-human animal, comprising the steps of providing a density gradient comprising at least two layers of the composition of the invention, each layer having a different density;separating the sperm sub-populations in the semen sample by centrifugation through the density gradient; and selecting the sperm sub-population of interest. Finally, the invention relates to spermatozoa prepared with the methods of the invention and the use of such spermatozoa in artificial insemination, in vitro fertilisation or intracytoplasmic sperm injection.